Two groups have filed a lawsuit over an executive order by West Virginia's governor granting religious exemptions from ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

European Union foreign policy chief Kaja Kallas shakes hands with North Macedonia's Prime Minister Hristijan Mickoski in Skopje, ...

In recent years, the Shazam! actor has courted controversy in Hollywood for endorsing U.S. President Donald Trump in the 2024 presidential election and for his comments about the Covid-19 vaccine.

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

World Health Organization (WHO) member countries adopted a new treaty on May 20, 2025, to improve international coordination ...

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

The much-anticipated report calls for increased scrutiny of the vaccine schedule and describes the nation’s children as overmedicated.

On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations.  The Vaccines and Related Biological Products Advisory ...